Dr. Tina Merritt Meinholz, a Bentonville-based allergy specialist, was on the team of doctors who developed the test for alpha-gal and discovered its association with tick bites. In 2004, biopharmaceutical company ImClone asked Dr. Thomas Platts-Mills at the University of Virginia to develop a test for severe reactions to the cancer drug Cetuximab, she said.